Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Tailored radiation boosts lung cancer fight

NCT ID NCT02473133

First seen Jan 03, 2026 · Last updated Jun 18, 2026 · Updated 29 times

Summary

This study tested a personalized approach to radiation therapy for people with stage III non-small cell lung cancer that cannot be removed by surgery. During standard chemoradiation, doctors used PET scans to see which parts of the tumor were still active and gave those areas a higher radiation dose. The goal was to improve tumor control without increasing side effects. The study involved 158 participants and compared this personalized method to standard treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Centre Henri Becquerel

    Rouen, 76038, France

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.